FDA’s notice to SRK, Devgn, Tiger
- Quaid Najmi
- 1 day ago
- 2 min read

Mumbai: Rattling Bollywood, the Maharashtra Food & Drugs Authority (FDA) has shot off notices to mega-star Shah Rukh Khan, Ajay Devgn and Tiger Shroff for allegedly promoting a banned product through surrogate advertising in the name Vimal Elaichi.
The notice has been issued by the FDA Assistant Commissioner (Food) N. T. Mujawar for Greate Mumbai Division and sought the stars’ written response along with supporting documents, either in person or through an authorised representative, within 15 days.
The FDA has listed eight points for prompt compliance by the actor, including one asking them to “immediately discontinue your participation in and endorsement of VIMAL Pan Masala/Elaichi advertisement,” to yank off the advertisement and promotional content from their social media handles, and not provide “any further cooperation or assistance in the broadcasting, publication, dissemination or promotion of the said advertisement in any form.”
The FDA warned: “The Authority is further empowered to prohibit the endorser of a false or misleading advertisement from making endorsement of any product or service for a period which may extend to one year, and for every subsequent contravention, up to three years.”
Additionally, Khan, Devgn and Shroff have been directed to furnish copies and details of their agreements or endorsement contracts, campaigns brief, product information, payment or endorsement arrangement, and details of the concerned advertising agency and brand owner, along with details of the due diligence undertaken by them and their agency prior to participating in the advertisement.
The FDA has demanded particulars of all television channels, digital and social media platforms and other media on which the advertisement has been broadcast, published or disseminated with their participation, together with the period of such broadcast or dissemination, and for disclosure of any material connection between themselves and the advertiser or brand owner as contemplated under the CCPA Guidelines, 2022.
“Furnish documentary evidence establishing whether VIMAL Elaichi is an independent product actually available for sale in the market, or whether the same constitutes a surrogate or brand extension communication intended to promote VIMAL Pan Masala/tobacco related products,” says the notice.
The star trio has been asked to furnish their written explanations as to “why legal action should not be initiated” against them for the prima facie violations of various provisions of the laws, as such advertisements may amount to “indirect or surrogate” promotion of prohibited pan masala and tobacco-related products.




Comments